Results 211 to 220 of about 42,113 (251)
I. IDC Key-note Lecture: Influence of gut microbiome in Duchenne muscular dystrophy. [PDF]
Iannotti FA.
europepmc +1 more source
Orthopaedic Management in Duchenne Muscular Dystrophy. [PDF]
Balachandran U, Mustapich T, Ranade SC.
europepmc +1 more source
Correction: Prognostic indicators of disease progression in Duchenne muscular dystrophy: A literature review and evidence synthesis. [PDF]
Ferizovic N+6 more
europepmc +1 more source
Preventing Cardiomyopathy in Duchenne Muscular Dystrophy: Long-Term Follow-Up of Patients in the Randomised, Placebo-Controlled Drug-Trial of Perindopril and Bisoprolol. [PDF]
Bourke JP+10 more
europepmc +1 more source
Failure to resolve inflammation contributes to juvenile onset cardiac damage in a mouse model of Duchenne muscular dystrophy. [PDF]
Novak JS+11 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The Lancet, 2001
Duchenne muscular dystrophy While the eponym, Duchenne muscular dystrophy (DMD), is applied to the most common and most severe muscular dystrophy of childhood, Duchenne was not the first to describe the condition. 10 years before Duchenne reported his first case of Duchenne dystrophy, the London physician Meryon had described the condition.
Jiri Vajsar, Venita Jay
openaire +3 more sources
Duchenne muscular dystrophy While the eponym, Duchenne muscular dystrophy (DMD), is applied to the most common and most severe muscular dystrophy of childhood, Duchenne was not the first to describe the condition. 10 years before Duchenne reported his first case of Duchenne dystrophy, the London physician Meryon had described the condition.
Jiri Vajsar, Venita Jay
openaire +3 more sources